Effect of surface roughness and thermal cycling on bond strength of C.P. titanium and Ti-6Al-4V alloy to ceramic

PurposeStudying the effect of surface roughness and thermal cycling on titanium–ceramic bonding.MethodsOne hundred fourteen samples in the form of bar for the C.P. titanium and Ti–6Al–4V alloy were used. They were divided into two groups according to the type of bar. Each group was then subdivided according to the type of surface treatment to three subgroups, control, airborne-particle abrasion and silica coated. Each subgroup was subdivided into two classes according to the type of test (surface roughness and bond strength). Samples used for the bond strength test were veneered. These samples were subdivided into two subclasses according to thermal cycling; whether without thermal cycling or after 6000 thermal cycles.ResultsThe surface roughness test results showed that silica coating recorded the highest surface roughness. Also C.P. titanium gave higher value of surface roughness than Ti–6Al–4V alloy. As regard the bond strength, the airborne-particle abrasion classes and the silica coated classes recorded bond strength values above the acceptable limit of 25 MPa determined in ISO 9693. As regard thermal cycling, the results showed that aging by thermal cycling decreased the metal–ceramic bond strength.ConclusionsThe airborne-particle abrasion and the silica coating are acceptable treatments for titanium–ceramic restorations. Increasing surface roughness of C.P. titanium and Ti–6Al–4V alloy not necessarily results in an increase in their bond strength to ceramics. Aging affects the metal–ceramic bond strength.     

Detection of Chikungunya virus in Aedes aegypti during 2011 outbreak in Al Hodayda, Yemen

In October 2010, the Ministry of Public Health and Population reported an outbreak of dengue-like acute febrile illness in Al Hodayda governorate. By January 2011, a total of 1542 cases had been recorded from 19 of the 26 districts in the governorate with 104 purportedly associated deaths. In response this event, in January 2011 entomological investigations aimed at identifying the primary vector and the epidemic associated etiological agent were carried out. Based on the reported cases and the progress of the outbreak in the governorate, mosquito collection was undertaken in two of the most recent outbreak areas; Al Khokha district (130 km south of Al Hodayda) and Al Muneera district (100 km north). Mosquito adults were collected from houses using BG-sentinel? traps, aspiration of resting mosquitoes and knock-down spraying. Indoor and outdoor containers adjacent to the houses were inspected for larvae. Subsequently mosquito pools were analyzed by RT-PCR for detection of the four dengue virus serotypes (DENV-1, DENV-2, DENV-3, DENV-4), and for Chikungunya virus (CHIKV). Aedes aegypti was the dominant mosquito species collected. Four pools represent 40% of the tested pools, all containing adult female Ae. aegypti, were positive for CHIKV. Three CHIKV isolates were obtained from the RNA positive mosquito pools and identified by rRT-PCR. This finding marks the first record of CHIKV isolated from Ae. aegypti in Yemen. The larval container and Breteau indices in the visited localities surveyed were estimated at 53.8 and 100, respectively. The emergence of this unprecedented CHIKV epidemic in Al Hodayda is adding up another arboviral burden to the already existing vector-borne diseases. Considering the governorate as one focal port in the Red Sea region, the spread of the disease to other areas in Yemen and in neighboring countries is anticipated. Public health education and simple measures to detect and prevent mosquito breeding in water storage containers could prevent and reduce the spread of mosquito-borne viruses like CHIKV and DENV in Yemen.     

Teaching children with autism to attend to socially relevant stimuli

Research has shown that children with autism often fail to attend to relevant stimuli in social situations, likely resulting in unsuccessful or absent social interactions. The purpose of this study was to teach children with autism to attend to stimuli with socially relevant features. Specifically, this study evaluated a teaching package including rules, modeling, role play, and specific feedback across multiple exemplars to teach children with autism to attend and respond to others’ bids for social attention (e.g., “Whoa!” or “Ouch!”). Three participants successfully learned to shift attention toward others and emit a response to gain more information in response to a socially relevant stimulus. Furthermore, generalization was observed across novel exemplars and people.     

Increased serum level of soluble receptor for advanced glycation end products (sRAGE) in type 2 diabetic patients with nephropathy

Activation of the receptor for advanced glycation end products (RAGE) has been implicated in the development of diabetic vascular complications. Soluble RAGE (sRAGE) could act as a decoy for the RAGE ligands and may thus exert a cytoprotective effect. Since RAGE is upregulated by advanced glycation end products (AGEs), the same could be implied for sRAGE. We aimed to investigate the role of sRAGE as a marker of early diabetic nephropathy. Forty-eight type 2 diabetic patients, further subdivided into group 1 without renal affection (10 patients), group 2 with microalbuminuria (25 patients), and group 3 with proteinuria (13 patients), and age-matched control group 4 (17 subjects) were included. Serum sRAGE, urea, creatinine, plasma glycated hemoglobin (HBA1c), and urinary albumin excretion (albumin/creatinine ratio) were measured. sRAGE levels were significantly higher in groups 2 and 3when compared to groups 1 and 4. No significant difference was found on comparing groups 2 and 3 together or on comparing groups 1 and 4. There was a significant positive correlation between sRAGE level and all the studied parameters (p?<?0.05) as well as a significant association between the sRAGE positivity within the three diabetic groups and the degree of proteinuria. Although sRAGE level was found to be significantly higher in the microalbuminuria group when compared to both the control and diabetics with normal kidney groups, the absolute value did not differ significantly from the proteinuria group. So we say that sRAGE can be used as a marker of diabetic nephropathy; however, its absolute level cannot be used to distinguish different degrees of renal affection.     

Differences in outcomes between cholecalciferol and ergocalciferol supplementation in veterans with inflammatory bowel disease

Aim: Vitamin D deficiency is a global health issue associated with increased health‐care costs, and could play a role in the pathogenesis and management of inflammatory bowel disease. Prior studies show a high prevalence of vitamin D deficiency in veterans with inflammatory bowel disease. We aimed to examine the outcome differences in patients with inflammatory bowel disease, comparing treatment with ergocalciferol to cholecalciferol. Methods: A retrospective review of electronic medical records of patients with inflammatory bowel disease at a Veterans Affairs Medical Facility in the Southeastern United States was carried out. Those with at least one serum 25(OH) vitamin D level were included. Initial and follow‐up vitamin D values were recorded. The type of vitamin D supplementation, whether cholecalciferol or ergocalciferol, was documented. Costs in the year after measurement of vitamin D were divided into separate inpatient and outpatient categories. Results: Veterans (n = 108) with ulcerative colitis or Crohn's disease and an available 25(OH) vitamin D level were studied. There were differences in follow‐up vitamin D levels; those who received weekly ergocalciferol had higher subsequent levels than those who received cholecalciferol, especially at a second follow up, although differences did not achieve statistical significance. However, those who received vitamin D3 were less likely to use laboratory, pharmacy, radiology and fee‐based services, and had lower laboratory and pharmacy costs. Conclusions: Our data suggest that cholecalciferol replacement might improve outcomes to a greater extent than ergocalciferol, and might be better in limiting health‐care costs and expenses in patients with inflammatory bowel disease. Geriatr Gerontol Int 2012; 12: 475–480.